CC
Commodore Capital Portfolio holdings
AUM
$1.42B
This Quarter Return
-0.98%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$473M
AUM Growth
+$473M
(+5.6%)
Cap. Flow
+$66M
Cap. Flow
% of AUM
13.96%
Top 10 Holdings %
Top 10 Hldgs %
75.64%
Holding
30
New
3
Increased
11
Reduced
4
Closed
6
Top Buys
| 1 |
Kura Oncology
KURA
|
$19.2M |
| 2 |
Merus
MRUS
|
$18.1M |
| 3 |
Day One Biopharmaceuticals
DAWN
|
$13.2M |
| 4 |
Cogent Biosciences
COGT
|
$13M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$11.9M |
Top Sells
| 1 |
C4 Therapeutics
CCCC
|
$11.7M |
| 2 |
BLU
BELLUS Health Inc.
BLU
|
$10.7M |
| 3 |
Protagonist Therapeutics
PTGX
|
$7.86M |
| 4 |
Karyopharm Therapeutics
KPTI
|
$7.33M |
| 5 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$3.85M |
Sector Composition
| 1 | Healthcare | 99.48% |
| 2 | Financials | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dyne Therapeutics
DYN
$1.92B
| – | – |
-305,125
| Closed | -$2.94M |
|
|
MREO
27
Mereo BioPharma
MREO
$275M
| – | – |
-1,954,970
| Closed | -$2.19M |
|
28
PMV Pharmaceuticals
PMVP
$82.1M
| – | – |
-125,000
| Closed | -$2.6M |
|
|
29
Protagonist Therapeutics
PTGX
$3.62B
| – | – |
-331,886
| Closed | -$7.86M |
|
|
GNCA
30
DELISTED
Genocea Biosciences, Inc.
GNCA
| – | – |
-3,079,756
| Closed | -$3.85M |
|